William Janssen Selected Research

William Janssen Research Topics

Disease

6	Neoplasms (Cancer) 04/2012 - 05/2002
3	Graft vs Host Disease (Graft-Versus-Host Disease) 09/2013 - 07/2010
2	Fibrosis (Cirrhosis) 01/2018 - 04/2014
2	Pneumonia (Pneumonitis) 01/2018 - 01/2013
2	Lung Diseases (Lung Disease) 01/2018 - 04/2014
2	Melanoma (Melanoma, Malignant) 10/2012 - 02/2007
2	Renal Cell Carcinoma (Grawitz Tumor) 01/2008 - 05/2002
2	Disease Progression 01/2008 - 02/2007
1	Parkinson Disease (Parkinson's Disease) 01/2022
1	Diabetic Nephropathies (Diabetic Nephropathy) 10/2020
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2020
1	Hypertension (High Blood Pressure) 01/2019
1	X-Linked Combined Immunodeficiency Diseases (X Linked Severe Combined Immunodeficiency) 01/2019
1	Hematologic Neoplasms (Hematological Malignancy) 02/2018
1	Residual Neoplasm 11/2017
1	Neuroblastoma 11/2017
1	Idiopathic Pulmonary Fibrosis 04/2014
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 04/2014
1	Lung Injury 01/2013
1	Acute Lung Injury 01/2013
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2013
1	Body Weight (Weight, Body) 04/2012
1	Glucose Intolerance 04/2012
1	Prostatic Neoplasms (Prostate Cancer) 04/2012
1	Sarcoma (Soft Tissue Sarcoma) 02/2012
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 10/2011
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 03/2011
1	Hypoalbuminemia 03/2011
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 03/2011
1	Mucositis 07/2010
1	Pathologic Complete Response 01/2008
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 02/2007
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 02/2006

Drug/Important Bio-Agent (IBA)

4	Interleukin-2 (IL2)IBA 11/2017 - 05/2002
3	CytokinesIBA 01/2018 - 01/2013
3	VaccinesIBA 01/2008 - 05/2002
2	Proteins (Proteins, Gene)FDA Link 10/2020 - 04/2012
2	Busulfan (Busulfex)FDA Link 11/2017 - 10/2011
2	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 11/2017 - 02/2007
2	Peptides (Polypeptides)IBA 04/2012 - 05/2002
2	Methotrexate (Mexate)FDA LinkGeneric 10/2011 - 07/2010
2	Tacrolimus (Prograf)FDA LinkGeneric 10/2011 - 07/2010
2	Mycophenolic Acid (Cellcept)FDA LinkGeneric 10/2011 - 07/2010
1	Glucosylceramidase (Glucocerebrosidase)IBA 01/2022
1	Superoxides (Superoxide)IBA 01/2020
1	Dasatinib (BMS 354825)FDA Link 01/2019
1	Interleukin-13IBA 01/2018
1	Melphalan (Alkeran)FDA LinkGeneric 11/2017
1	Hydroxyproline (4 Hydroxyproline)IBA 04/2014
1	CollagenIBA 04/2014
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2014
1	indium-bleomycinIBA 04/2014
1	Minor Histocompatibility AntigensIBA 09/2013
1	EndotoxinsIBA 01/2013
1	Interleukin-6 (Interleukin 6)IBA 01/2013
1	Biomarkers (Surrogate Marker)IBA 01/2013
1	CorticosteroneIBA 04/2012
1	EnzymesIBA 04/2012
1	AndrogensIBA 04/2012
1	ImmunosorbentsIBA 04/2012
1	fludarabineIBA 10/2011
1	Sirolimus (Rapamycin)FDA Link 10/2011
1	Serum AlbuminIBA 03/2011
1	Narcotics (Narcotic Analgesics)IBA 07/2010
1	CD40 Ligand (CD40L)IBA 02/2007
1	Cancer VaccinesIBA 02/2006
1	Neoplasm Antigens (Tumor Antigens)IBA 05/2002

Therapy/Procedure

3	Drug Therapy (Chemotherapy) 01/2019 - 02/2006
3	Injections 04/2012 - 02/2007
2	Hematopoietic Stem Cell Transplantation 01/2019 - 03/2011
2	Transplantation 02/2018 - 09/2013
2	Immunotherapy 11/2017 - 02/2006
2	Therapeutics 11/2017 - 02/2012
2	Cell Transplantation 11/2017 - 10/2011
2	Radiotherapy 04/2012 - 02/2012
1	Artificial Respiration (Mechanical Ventilation) 01/2013
1	Homologous Transplantation 10/2011
1	Analgesia 07/2010
1	Parenteral Nutrition 07/2010